Terms: = Colorectal cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Staging
16 results:
1. Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways.
Sihag S; Nussenzweig SC; Walch HS; Hsu M; Tan KS; Sanchez-Vega F; Chatila WK; De La Torre SA; Patel A; Janjigian YY; Maron S; Ku GY; Tang LH; Hechtman J; Shah PM; Wu AJ; Jones DR; Molena D; Solit DB; Schultz N; Berger MF
Clin Cancer Res; 2021 Jun; 27(12):3491-3498. PubMed ID: 33795256
[TBL] [Abstract] [Full Text] [Related]
2. Butyrate-Induced In Vitro Colonocyte Differentiation Network Model Identifies ITGB1, SYK, cdkn2a, CHAF1A, and LRP1 as the Prognostic Markers for colorectal cancer Recurrence.
Dasgupta N; Kumar Thakur B; Chakraborty A; Das S
Nutr Cancer; 2019; 71(2):257-271. PubMed ID: 30475060
[TBL] [Abstract] [Full Text] [Related]
3. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C
BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of magnetic resonance imaging in staging of rectal cancer and its relationship with p16 expression.
Zheng N; Li YY; Cao YC; Liu S; Wang CH; Liu WJ
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3755-3762. PubMed ID: 29949150
[TBL] [Abstract] [Full Text] [Related]
5.
Sideris M; Moorhead J; Diaz-Cano S; Haji A; Papagrigoriadis S
Anticancer Res; 2017 Mar; 37(3):1349-1357. PubMed ID: 28314302
[TBL] [Abstract] [Full Text] [Related]
6. An update on anal neoplasia.
Fléjou JF
Histopathology; 2015 Jan; 66(1):147-60. PubMed ID: 25283345
[TBL] [Abstract] [Full Text] [Related]
7. Expression of cell cycle regulatory factors hus1, gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock gene per2 in human colorectal carcinoma tissue.
Štorcelová M; Vicián M; Reis R; Zeman M; Herichová I
Mol Biol Rep; 2013 Nov; 40(11):6351-61. PubMed ID: 24062075
[TBL] [Abstract] [Full Text] [Related]
8. Predicting metachronous liver metastasis from colorectal cancer using serum proteomic fingerprinting.
Zhu D; Zhong Y; Wu H; Ye L; Wang J; Li Y; Wei Y; Ren L; Xu B; Xu J; Qin X
J Surg Res; 2013 Oct; 184(2):861-6. PubMed ID: 23721930
[TBL] [Abstract] [Full Text] [Related]
9. UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.
Wang F; Yang YZ; Shi CZ; Zhang P; Moyer MP; Zhang HZ; Zou Y; Qin HL
Ann Surg Oncol; 2012 Aug; 19(8):2753-62. PubMed ID: 22219067
[TBL] [Abstract] [Full Text] [Related]
10. Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer--a case control study.
Krupa R; Sliwinski T; Wisniewska-Jarosinska M; Chojnacki J; Wasylecka M; Dziki L; Morawiec J; Blasiak J
Mol Biol Rep; 2011 Apr; 38(4):2849-54. PubMed ID: 21104022
[TBL] [Abstract] [Full Text] [Related]
11. p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types.
Lam AK; Ong K; Giv MJ; Ho YH
Pathology; 2008 Oct; 40(6):580-5. PubMed ID: 18752124
[TBL] [Abstract] [Full Text] [Related]
12. colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression.
Lam AK; Ong K; Ho YH
Dis Colon Rectum; 2006 Sep; 49(9):1275-83. PubMed ID: 16912910
[TBL] [Abstract] [Full Text] [Related]
13. Microdissection-based allelotyping: a novel technique to determine the temporal sequence and biological aggressiveness of colorectal cancer.
Gamblin TC; Finkelstein SD; Upsal N; Kaye JD; Blumberg D
Am Surg; 2006 May; 72(5):445-53. PubMed ID: 16719202
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemical evaluation of thymidylate synthase (TS) and p16ink4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
[TBL] [Abstract] [Full Text] [Related]
15. p16 gene methylation in colorectal cancers associated with Duke's staging.
Yi J; Wang ZW; Cang H; Chen YY; Zhao R; Yu BM; Tang XM
World J Gastroenterol; 2001 Oct; 7(5):722-5. PubMed ID: 11819863
[TBL] [Abstract] [Full Text] [Related]
16. Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells.
Schwartz B; Avivi-Green C; Polak-Charcon S
Mol Cell Biochem; 1998 Nov; 188(1-2):21-30. PubMed ID: 9823007
[TBL] [Abstract] [Full Text] [Related]
